Biomarkers and AI for the transformation of heart failure diagnosis

The ESC Heart Failure Guidelines recommend measurement of plasma NT-proBNP concentration as an initial step, and echocardiography as a necessary tool to confirm HF diagnosis, as well as to distinguish between types of HF.

Nt-proBNP biomarker testing and echocardiography delivered in primary care and community settings could potentially expand access to screening and enable earlier and guideline-compliant diagnosis of HF.

AI allows fully automated echocardiographic image analysis and provides decision support reports for disease detection.